Tx: Induction therapy at time of transplant - used in combination
MOA - binds IL-2 receptor (CD25 antigen) on activated T cells and inhibits IL2- mediated T cells effects
May not be as effective as ATG
Adverse effects -No cytokine release reaction and T cell depletion
5
New cards
Prednisone (oral)
Glucocorticoid
Tx: Induction therapy in combination - Lower does: maintenance therapy
MOA - Interferes with NFkB activation & activity reducing cytokine production & secretion, thereby reducing macrophage & T cell activation and T & B cell replication
Tx: Prophylaxis of transplant rejection - Used in combination w/ glucocorticoids and a calcinerin inhibitor
MOA - inhibitor of inosine monophosphate dehydrogenase, an enzyme required for guanine nucleotide synthesis and B and T cell replication
Adverse effect - GI and hematologic toxicities - Teratogenic
7
New cards
Tacrolimus (Oral/IV)
Calcineurin inhibitors
Tx: Prophylaxis of transplant and allograft rejection
MOA - inhibits activity of calcineurin a phosphatase enzyme that activates a transcription factor (NF-AT) required for IL2 production in T cells
Adverse effects - Nephrotoxicity;
8
New cards
Sirolimus (oral)
mTOR antagonist
MOA - inhibits activity of mTOR, a protein kinase required for cell cycle progression from G1 to S phase
Adverse effects -
9
New cards
Mannitol (IV)
Osmotic Diuretic
Descending loop of Henle, Proximal tubule, CD
Tx: Cerebral edema, glaucoma
MOA - Increases osmotic pressure, drawing water out of cells and expanding extracellular fluid volume Reduces reabsorption of water in the proximal tubule, descending loop of Henle, and collecting ducts
Side effects - Hyponatremia followed by hypernatremia; headache, nausea, vomiting
Tx: Pulmonary edema, other edema, CHF, hypercalcemia, HTN
MOA - Blocks NKCC channel in TAL, increasing urinary Na+ and Cl- excretion; also increases Ca2+ and Mg2+ excretion Powerful diuretic
Side effect - Hypovolemia, hypokalemia, hypomagnesemia, hypocalcemia, hyperuricemia, increased RAAS activity due to blocked tubuloglomerular feedback, hypersensitivity (sulfa), reduced efficacy with NSAIDs, probenecid, penicillin
13
New cards
Spironolactone
K+ sparing diuretic
Collecting duct
Tx: Used in combination with other diuretics to prevent K+ loss; CHF, hyperaldosteronism
MOA: - Aldosterone receptor antagonist; decreases expression of ENaC and Na+/K+ ATPase in collecting duct principal cells; increases Na+ excretion and decreases K+ excretion
Side effects - Hyperkalemia Gynecomastia, menstrual irregularities, impotence
14
New cards
Amiloride
K+ sparing diuretics
Collecting duct
Tx: Used in combination to treat hypokalemia riks, Liddle’s disease, lithium-induced diabetes insipidus
MOA - Blocks ENaC in the collecting tubule, reducing Na+ reabsorption and K+ secretion by principal cells; also decreases H+ secretion by intercalated cells